Ideaya Biosciences Inc Earnings

The next earnings date for Ideaya Biosciences Inc is November 4, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Ideaya Biosciences Inc Earnings

Report Date	Estimated Earnings Per Share
11/04/2025	$-0.55

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Ideaya Biosciences Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/12/2025	---	$-0.88	-11.34%
05/05/2025	Before Market	$-1.49	-121.30%
02/18/2025	Before Market	$-1.49	-139.36%
11/05/2024	Before Market	$-0.60	4.76%
08/06/2024	Before Market	$-0.68	-25.93%
05/07/2024	Before Market	$-0.53	-3.92%
02/20/2024	Before Market	$-0.52	-10.64%
11/07/2023	Before Market	$-0.46	6.12%
08/10/2023	Before Market	$-0.50	10.71%
05/09/2023	Before Market	$-0.49	10.91%
03/07/2023	Before Market	$-0.50	10.71%
11/08/2022	Before Market	$0.04	106.45%
08/15/2022	Before Market	$-0.57	-9.62%
05/10/2022	Before Market	$-0.36	12.20%
03/15/2022	Before Market	$-0.47	-51.61%
11/15/2021	Before Market	$-0.31	-3.33%
08/10/2021	Before Market	$-0.33	-230.00%
05/10/2021	Before Market	$-0.28	-3.70%
03/23/2021	Before Market	$-0.18	40.00%
11/12/2020	Before Market	$-0.17	-115.04%
08/12/2020	Before Market	$-0.59	-132.24%
05/12/2020	Before Market	$-0.59	-3.51%
03/24/2020	Before Market	$-0.53	7.02%
11/13/2019	Before Market	$-0.54	18.18%
08/12/2019	After Market	$-1.30	-103.13%
05/28/2019	After Market	$-1.76	---

More About Ideaya Biosciences Inc

Website

https://www.ideayabio.com

Country

USA

Full Time Employees

131

IDEAYA Biosciences, Inc., a precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company's products in development include IDE196, a protein kinase C inhibitor that is in Phase 2/3 clinical trials for genetically defined cancers having GNAQ or GNA11 gene mutations; IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase 2 clinical trials for patients with solid tumors having methylthioadenosine phosphorylase gene deletions, such as non-small cell lung (SCLC) and MTAP-deletion urothelial cancer; IDE849, a DLL3 antibody drug conjugate inhibitor that is in Phase 1 clinical trial for the treatment of SCLC and neuroendocrine tumors; IDE275, a Werner Helicase inhibitor that is in Phase 1 clinical trial for patients having tumors with high microsatellite instability; IDE161, a poly ADP-ribose glycohydrolase inhibitor that is in Phase 1/2 clinical trial to treat tumors with homologous recombination deficiency (HRD), and other genetic or molecular signatures; IDE705 (GSK101), a Poly Theta Helicase inhibitor that is in Phase 1 clinical trial for the treatment of tumors with BRCA or other mutations associated with HRD. It also develops preclinical programs, including IDE892, a MTA-cooperative PRMT5 inhibitor; IDE034, a B7H3/PTK7 topo-I-payload bispecific BsADC; and IDE251, a KAT6/7 inhibitor. In addition, the company offers preclinical research programs focused on pharmacological inhibition; DECIPHER dual CRISPR library for synthetic lethality target and biomarker discovery; and INQUIRE chemical library and HARMONY machine-learning engines to enhance its drug discovery platform. The company has strategic alliances with GlaxoSmithKline, Pfizer Inc., Gilead Sciences, Inc., Merck, Biocytogen, Cancer Research UK, and the University of Manchester. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

“Ideaya Biosciences Inc Earnings” Can Refer to the Ideaya Biosciences Inc Earnings Date

Some people say “Ideaya Biosciences Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Ideaya Biosciences Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Ideaya Biosciences Inc Stock on the Earnings Date

If you own Ideaya Biosciences Inc stock (IDYA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Ideaya Biosciences Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Ideaya Biosciences Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Ideaya Biosciences Inc Earnings

You can contact us any time if you would like to ask questions about Ideaya Biosciences Inc earnings or anything else related to the stock market.